2.Pathologic features of recently identified renal cell carcinoma.
Xiang FAN ; Qiu RAO ; Li-hua ZHANG
Chinese Journal of Pathology 2013;42(8):569-573
Adenocarcinoma, Follicular
;
genetics
;
metabolism
;
pathology
;
Carcinoma, Papillary
;
genetics
;
metabolism
;
pathology
;
Carcinoma, Renal Cell
;
genetics
;
metabolism
;
pathology
;
Diagnosis, Differential
;
Humans
;
Immunohistochemistry
;
Kidney Diseases, Cystic
;
genetics
;
metabolism
;
pathology
;
Kidney Neoplasms
;
genetics
;
metabolism
;
pathology
;
Thyroid Neoplasms
;
genetics
;
metabolism
;
pathology
;
Translocation, Genetic
3.The advances of molecular pathology of follicular thyroid carcinoma.
Chinese Journal of Pathology 2004;33(3):268-270
Adenocarcinoma, Follicular
;
genetics
;
metabolism
;
pathology
;
Biomarkers, Tumor
;
genetics
;
Diagnosis, Differential
;
Humans
;
Matrix Metalloproteinase 1
;
biosynthesis
;
genetics
;
Telomerase
;
biosynthesis
;
genetics
;
Thyroid Neoplasms
;
genetics
;
metabolism
;
pathology
;
ras Proteins
;
biosynthesis
;
genetics
4.Familial papillary thyroid carcinoma.
Qinghai JI ; Yi WU ; Yongxue ZHU ; Yu WANG ; Rongmei ZHANG ; Zewei LUO
Chinese Journal of Surgery 2002;40(8):564-566
OBJECTIVETo investigate the clinical features of familial papillary thyroid carcinoma (FPTC) and the criteria for its diagnosis and surgical treatment.
METHODSOne hundred and forty-five patients with PTC were investigated randomly between January 1999 and November 2001, and 17 of them were from 7 families. Of the 17 patients, 14 were operated on at this hospital, and 3 were operated elsewhere. The specimens from the 17 patients were confirmed pathologically. They accounted for 9.3% (14/145) of all PTC patients.
RESULTSThe patients were aged from 30 to 74 years (mean 45 years). The diameter of original focuses ranged from 0.8 to 2.8 cm (mean diameter 1.7 cm). Of the 17 patients with PTC, 8 (47.5%) had bilateral carcinoma. In 3 families, 3 patients suffered from PTC (42.8%). In 4 families, other members suffered from benign thyroid tumor or non-tumorous thyroid disease. Among the 17 patients, 10 had nodular goiters. Thyroidectomy, unilateral thyroidectomy plus isthmusectomy, and combined radical operation were performed in 8, 9, 14 patients, respectively. Early metastatic spread to local regional lymph nodes was noted in 14 patients (82.3% or 14/17).
CONCLUSIONSIn this study, a FPTC rate of 10% was found. Almost 50% of FPTC patients had bilateral carcinoma. The frequency of metastatic spread to local-regional lymph nodes was high. Follow-up survey of family members should be performed in a long period of time.
Adult ; Aged ; Carcinoma, Papillary ; genetics ; pathology ; surgery ; Female ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Thyroid Neoplasms ; genetics ; pathology ; surgery ; Thyroidectomy
5.One case of throat B-cell lymphoma with ipsilateral thyroid papillary carcinoma.
Zhenying CUI ; Bo ZHOU ; Zehai DENG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2013;27(21):1220-1221
UNLABELLED:
A female patient of 56 years old had hoarseness that seems worse after talking excessively,which occasionally associated with slightly sore throat and pharyngeal foreign body sensation. The symptoms are not associated with sore throat, fever, night sweats, not drinking cough, breathing and swallowing difficulties, but no cough, bloody sputum. Neck ultrasound can be showed: goiter and real echo uneven thickening, increased blood supply pan; the right thyroid lobe multiple cysts pan. Enhanced CT shows occupying lesions were found out in the right side of the supraglottic larynx gap and the right lobe of the thyroid, nature to be determined. Full thyroid function showed: thyroid microsomal antibodies 278.2 u/ml, the rest of the indicators in the normal range. Other routine preoperative examinations were normal. Immunohistochemistry: CD45(++) CD68(+) CD99(++) EMA(-) CK(-) Sclc(-) TTF-1(--) CgA(-) SY(-) NSE(--) S-100(-) ESA(-). Supported by immunohistochemistry, hyperplasia organizations was diffuse lymphoid tissue. Through expert consultation by superior hospital the pathology showed: Hashimoto's thyroiditis with thyroid papillary carcinoma (lesions of the right thyroid); Lesion on the right side of the throat gene rearrangement results show: B lymphocyte clonal consider mucosa-associated extranodal marginal zone B-cell lymphoma the gene rearrangement that the right side of the throat disease is: B lymphocyte clonal, be considerd mucosa-associated extranodal marginal zone B-cell lymphoma.
DIAGNOSIS
throat B-cell lymphoma; thyroid papillary carcinoma (right side); Hashimoto's thyroiditis (right side).
Carcinoma
;
pathology
;
Carcinoma, Papillary
;
pathology
;
Female
;
Hashimoto Disease
;
pathology
;
Humans
;
Immunohistochemistry
;
Lymphoma, B-Cell, Marginal Zone
;
genetics
;
pathology
;
Middle Aged
;
Neck
;
Neoplasms, Multiple Primary
;
pathology
;
Pharyngeal Neoplasms
;
pathology
;
Pharynx
;
Thyroid Cancer, Papillary
;
Thyroid Neoplasms
;
pathology
6.International collaborations preparing for a cancer "moon shot": a summary of the Sino-US Symposium on Head and Neck Cancer.
Chinese Journal of Cancer 2012;31(3):121-125
Oncologists and scientists in the field of head and neck cancer exchanged their research findings and clinical experiences in the Sino-USA Symposium on Head and Neck Cancer, which was held January 6-7, 2012 in Guangzhou, China. The symposium was jointly organized by Sun Yat-sen University Cancer Center (SYSUCC) and the University of Texas MD Anderson Cancer Center (MDACC). The Guangdong Provincial Anti-Cancer Association and the Chinese Journal of Cancer also helped in organizing the conference. Speakers were from China (SYSUCC, the Chinese University of Hong Kong, Tianjin Medical University Cancer Institute and Hospital, and Fudan University Shanghai Cancer Center) and the United States (MDACC). The presentations covered most kinds of head and neck cancers and included both basic and clinical research progress. In particular, NPC was discussed in depth. The symposium explored the reality that cancer is complex and numerous questions remain to be answered, even though there has already been an enormous effort into research. International exchanges of experience and in-depth cooperation are definitely needed to improve our capability of caring for cancer patients. In this article, we provide highlights of the presentations.
Carcinoma, Squamous Cell
;
genetics
;
Combined Modality Therapy
;
Drug Delivery Systems
;
Head and Neck Neoplasms
;
drug therapy
;
etiology
;
genetics
;
pathology
;
surgery
;
Humans
;
Nasopharyngeal Neoplasms
;
genetics
;
pathology
;
therapy
;
Thyroid Neoplasms
;
epidemiology
7.A Case of Multiple Endocrine Neoplasia Type 1 Combined with Papillary Thyroid Carcinoma.
Hai Jin KIM ; Jong Suk PARK ; Chul Sik KIM ; Eun Seok KANG ; Bong Soo CHA ; Sung Kil LIM ; Kyung Rae KIM ; Hyun Chul LEE ; Chul Woo AHN
Yonsei Medical Journal 2008;49(3):503-506
This is the first report of papillary thyroid carcinoma combined with multiple endocrine neoplasia type 1 (MEN1) in Korea. MEN1 is a hereditary disease comprising neoplastic disorders such as pituitary, parathyroid and pancreatic neuroendocrine tumor, such as gastrinoma. But papillary thyroid cancer was never regarded as its component before in Korea. Herein we present a 39-year-old woman who manifested typical features of MEN1 with a coincidental papillary thyroid carcinoma. Although the family history of MEN1 was definite, her genetic analysis of DNA had revealed no germline mutation in MEN1 gene locus. Unidentified culprit gene unable us further genetic study to find LOH (loss of heterogeneity) in 11q13, the possible explanation of papillary thyroid carcinoma as a new component of MEN1. As we have first experienced a case of MEN1 combined with papillary thyroid carcinoma in Korea, we report it with the review of literature.
Adult
;
Carcinoma, Papillary/genetics/*pathology
;
Diagnosis, Differential
;
Female
;
Humans
;
Multiple Endocrine Neoplasia Type 1/genetics/*pathology
;
Mutation
;
Proto-Oncogene Proteins/genetics
;
Thyroid Neoplasms/genetics/*pathology
8.Progression of solitary and multifocal papillary thyroid carcinoma - a retrospective study of 368 patients.
Xiang-qian ZHENG ; Chen WANG ; Meng XU ; Yang YU ; Xin-wei YUN ; Yong-sheng JIA ; Song-feng WEI ; Xiu-bao REN ; Ming GAO
Chinese Medical Journal 2012;125(24):4434-4439
BACKGROUNDPapillary thyroid carcinoma (PTC) represents one of the most frequent endocrine malignancies. Several factors have been found to be involved in determining the outcome of treatment for patients with PTC. Large tumor size, diagnosis at an early age, extra-thyroidal invasion, aggressive histological variants, and distant metastases are the most important determinants of a poor outcome. BRAF(V600E) mutation has been found to be a major genetic alteration in PTC. This study aimed to evaluate progression in patients with multifocal and solitary PTC.
METHODSWe performed a retrospective study to analyze 368 patients with PTC who underwent surgery, including 282 patients with solitary PTC and 86 patients with multifocal PTC. The status of BRAF(V600E) mutation in all tumor foci from multifocal PTC was detected.
RESULTSOur study suggested that multifocal PTC was more related to lymph node metastasis and vascular invasion than solitary PTC. However, the distant metastasis rate and 10-year survival rate showed no difference between these two groups. The number of tumor foci did not affect progression of disease in multifocal PTC patients. Lymph node metastasis in multifocal PTC patients was associated with larger tumors, diagnosis at early stage, and extra-thyroidal invasion.
CONCLUSIONThe status of BRAF(V600E) mutation was more frequent in multifocal PTC patients with lymph node metastasis and diagnosis at later age.
Adult ; Aged ; Carcinoma ; genetics ; pathology ; Carcinoma, Papillary ; genetics ; pathology ; Female ; Humans ; Male ; Middle Aged ; Mutation ; Proto-Oncogene Proteins B-raf ; genetics ; Retrospective Studies ; Thyroid Neoplasms ; genetics ; pathology
9.Quantitative analysis of thyroid transcription factor-1 mRNA expressions in primary lung cancer and its metastatic foci.
Journal of Southern Medical University 2008;28(1):20-25
OBJECTIVETo observe the expression of thyroid transcription factor-1 (TTF-1) mRNA in human normal adult type II alveolar epithelial cells, embryonic alveolar epithelial cells, and primary lung carcinoma and lymph nodes, thereby exploring the role of TTF-1 mRNA expression in the tumorigenesis, development and metastasis of lung carcinoma.
METHODSTTF-1 mRNA was detected using tissue microarray and in situ hybridization in 1320 different paraffin-embedded tissue specimens. The intensity of TTF-1 mRNA in these tissues was assessed quantitatively using Leica Q500MC image analysis system.
RESULTSTTF-1 mRNA expression was significantly less intense in embryonic lung than in normal adult lung tissues (P= 0.000), and the two tissues both had significantly greater expression than lung adenocarcinoma, squamous cell carcinoma, small cell carcinoma and large cell carcinoma (P=0.000). Lung adenocarcinoma and small cell carcinoma, with similar expression intensity (P= 0.068), showed stronger expression than squamous cell carcinoma and large cell carcinoma (P=0.000), and squamous cell carcinoma showed stronger expression than large cell carcinoma (P=0.018). In lung adenocarcinoma, squamous cell carcinoma and large cell carcinoma, the intensity of TTF-1 mRNA expression was stronger in lymph node metastases than in the primary foci (P=0.003, P=0.000, P=0.019, respectively). The lymph node metastases had more intense expression than the primary foci of small cell lung carcinoma (P=0.078). The intensity of TTF-1 mRNA expression was greater in primary lung carcinomas with lymph node metastases than in those without metastases (P=0.026). Tumors of TNM stage II-IV had stronger expression than those of stage I (P=0.010). The intensity of TTF-1 mRNA expression was not associated with the patients' gender or the general types and differentiation of the tumor.
CONCLUSIONThe amount of TTF-1 mRNA expression lowers in the order of normal adult lung, embryonic lung and lung carcinoma tissues. In lung carcinomas, TTF-1 mRNA expression differs between the histological types, high in lung adenocarcinoma and small cell carcinoma and rather low in squamous cell carcinoma and large cell carcinoma. Strong expression of TTF-1 mRNA often indicates high likeliness of lung carcinoma metastasis, and highlights the high metastatic potentials of lung adenocarcinoma, squamous cell carcinoma and large cell carcinoma.
Adenocarcinoma ; genetics ; pathology ; Carcinoma, Squamous Cell ; genetics ; pathology ; Female ; Humans ; In Situ Hybridization ; Lung Neoplasms ; genetics ; pathology ; Lymphatic Metastasis ; Male ; Nuclear Proteins ; genetics ; RNA, Messenger ; biosynthesis ; genetics ; Thyroid Gland ; metabolism ; Thyroid Nuclear Factor 1 ; Tissue Array Analysis ; methods ; Transcription Factors ; genetics
10.Clinical significance of multigene assay in papillary thyroid carcinoma.
Yuan SHI ; Kai QIAN ; Kai GUO ; Jun LIU ; Zhuoying WANG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2023;37(5):375-379
Objective:To analyze the clinical significance of multigene assay in papillary thyroid carcinoma(PTC). Methods:Patients who underwent thyroidectomy in a tertiary hospital from August 2021 to May 2022 were enrolled. The eight-gene panel was used to detect the tumor tissue of patients, and the correlation between gene mutations and clinical features was analyzed. Results:Among 161 patients, mutation rate of BRAF V600E, RET/PTC1 and TERT promotor were 82.0%, 6.8% and 4.3%, respectively. BRAF V600E mutation was more common in male patients(P=0.023). TERT promotor-mutated tumors had a large diameter(P=0.019), a high proportion of multifocal lesions(P=0.050), and a large number of lymph node metastases(P=0.031). Among 89 patients who completed preoperative BRAF detection, there was a strong consistency between the preoperative aspiration test and postoperative panel(Cohen κ=0.694, 95%CI: 0.482-0.906, P<0.01). In the hematoxylin-eosin sections obtained from 80 patients, BRAF V600E was still the main type of gene mutation, and the classical/follicular type was more distributed. TERT promotor and RET/PTC1 mutation were the main genetic events for tall-cell/columnar/hobnail type and diffuse sclerosing type, respectively. One-way ANOVA showed that there were differences in diagnosis age(P=0.029) and tumor size(P<0.01) among different pathological types. Conclusion:As a simple and feasible clinical detection method for PTC, the multigene assay can supplement the identification of important genetic events other than BRAF V600E, and provide more prognostic information and follow-up hints for postoperative patients.
Humans
;
Male
;
Thyroid Cancer, Papillary/genetics*
;
Thyroid Neoplasms/pathology*
;
Proto-Oncogene Proteins B-raf/genetics*
;
Clinical Relevance
;
Carcinoma, Papillary/pathology*
;
Mutation